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Clinical presentation and vascular imaging in giant
cell arteritis of the femoropopliteal and
tibioperoneal arteries. Analysis of four cases
Federico Tatò, MD, and Ulrich Hoffmann, MD, Munich, Germany
We present four patients with rapidly progressive claudication of the lower limbs due to extracranial giant cell arteritis.
Additional findings suggestive of giant cell arteritis were involvement of the axillary or brachial arteries in two patients,
symptoms of polymyalgia rheumatica or temporal arteritis in three, and all patients had severely elevated erythrocyte
sedimentation rate and C-reactive protein level. Lower limb involvement affected preferentially the femoropopliteal, deep
femoral, and tibioperoneal arteries. Hypoechogenic, concentric mural thickening suggestive of vasculitis was readily
visible in all involved arterial segments by duplex ultrasound imaging, whereas angiography was rather unspecific. Typical
changes for large-vessel vasculitis were also detectable by magnetic resonance imaging and fluorine-18-desoxyglucose
positron emission tomography. More widespread use of these vascular imaging techniques may show that giant cell
arteritis of the lower limbs is more frequent than previously assumed. (J Vasc Surg 2006;44:176-82.)Giant cell arteritis (GCA) is a chronic vasculitis of large-
and medium-sized arteries that almost exclusively affects
elderly patients. Involvement of the cranial arteries leads to
the classic symptoms of headache, painful thickening of the
temporal artery, jaw claudication, and visual loss.1 The
most common extracranial manifestation of GCA is steno-
sis or occlusion of the subclavian and axillary artery, with
loss of arm pulses and upper limb claudication.2
Involvement of the lower limbs is considered rare in
GCA. So far, only a few cases of GCA with involvement of
the iliac or femoropopliteal arteries have been reported.3-7
However, the true frequency of lower limb GCA may be
underestimated if the involvement of this vascular region
remains silent or if it is confused with arteriosclerotic vas-
cular disease.
Duplex ultrasound imaging,8 magnetic resonance im-
aging (MRI),9,10 and fluorine-18-desoxyglucose positron
emission tomography (18F-FDG-PET)11-13 have greatly
improved the noninvasive diagnosis of large-vessel vasculi-
tis. These methods allow the detection of arterial inflam-
mation while still at an early stage, even in asymptomatic
patients. More widespread use of these imaging techniques
may reveal that lower limb artery involvement in GCA is
more common than previously assumed.
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176We recently observed four patients with GCA involving
the femoropopliteal and crural arteries who presented with
typical symptoms of lower limb ischemia mimicking arte-
riosclerotic peripheral arterial disease. We present the key
clinical findings in this unusual cause of peripheral arterial
disease and discuss our experience with digital subtraction
angiography, duplex sonography, MRI, and 18F-FDG-
PET in the diagnostic work-up of these patients.
CASE REPORTS
The patients were two men and two women aged between 58
and 73 years. The key clinical findings of the four patients are
summarized in Tables I and II. Claudication was preceded by
several months of malaise and typical symptoms of polymyalgia
rheumatica in patients 1, 2, and 4. Two patients complained of
temporal headache, and one had sudden blindness of the left eye
due to optic nerve ischemia 4 months before the onset of claudi-
cation.
Temporal artery biopsy was performed on three patients, and
the specimen was positive for GCA in two. Patient 4, who did not
have a biopsy, had clinically normal temporal arteries and no signs
of temporal arteritis in duplex sonography.
Before the onset of prednisone treatment, all patients had a
markedly elevated erythrocyte sedimentation rate (ESR) and
plasma C-reactive protein (CRP). Three patients had mild, medi-
cally controlled hypertension; patient 4 had quit smoking 5 years
prior (25 pack-years). None of the patients was diabetic or had
hyperlipidemia.
Pattern of extracranial artery involvement. Two patients
had involvement of both upper and lower limbs, and two patients
only of the lower limbs (Table II). Upper limb involvement
consisted of occlusion of both axillary arteries in patient 3 and long,
high-grade stenosis of both axillary and brachial arteries in patient
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tient 3 and caused mild arm claudication in patient 2.
All patients complained of rapidly progressive, bilateral calf and
foot claudication. Measurements of ankle pressures and pulse volume
recordings showed compensated lower limb perfusion in patients 3
and 4 (systolic ankle pressures 70 mm Hg and abnormal but
pulsatile pulse volume recordings of the foot) and critical limb isch-
emia in patients 1 and 2 (Table II). Patient 1 presented with nocturnal
rest pain of the right foot and a small ischemic ulceration at the tip of
the right hallux. Patient 2 complained of intermittent rest pain in both
feet and had bilateral interdigital lesions.
The physical examination and the results of vascular imaging
demonstrated symmetrical involvement of the popliteal and crural
Table I. Symptoms at initial presentation, results of tempo
four patients with peripheral arterial disease due to giant ce
Patient 1
Gender/age (years) Male/73 Ma
Classic symptoms of giant cell
arteritis
Pain in shoulders and
neck, arthralgia,
morning stiffness,
temporal headache,
fatigue, unilateral
optic nerve ischemia
Pai
p
a
s
t
l
f
e
Temporal biopsy Positive Pos
ESR mm/h 102 85
CRP mg/dL 8.90 7.6
ESR, Erythrocyte sedimentation rate; CRP, C-reactive protein.
Table II. Hemodynamic findings, traditional cardiovascul
and performed vascular imaging in four patients with perip
Patient 1
Vascular symptoms Bilateral calf claudication,
rest pain in the right foot,
ischemic lesion of the
right hallux
Bil
f
i
b
Ankle pressures* (right/left) 40/105 mm Hg 60/
ABI (right/left) 0.25/0.66 NR
PVR of the foot (right/left) Flat/abnormal‡ Fla
Traditional risk factors Hypertension No
Distribution of peripheral
arterial involvement
Multiple stenoses of both
SFAs, PAs, and DFAs;
occlusion of the right
tibioperoneal trunk;
multiple occlusions of the
TPAs
Mu
b
s
b
a
T
s
a
Imaging tests performed Duplex, DSA, MRI, PET Du
PVR, Pulse volume recording; ABI, ankle/brachial index; NR, not reporte
TPA, tibioperoneal arteries; AA, axillary artery; BA, brachial artery; DSA, d
emission tomography.
*Systolic pressures were measured in the posterior tibial and dorsalis pedis a
†ABI is not reported due to false-low brachial pressures in patients with upp
‡Indicates pathologic but pulsatile PVR.arteries in all patients. The superficial femoral arteries were involved inpatients 1 and 3. Involvement of the deep femoral arteries was
documented in patients 1 and 2, who were evaluated by digital
subtraction angiography. None of the patients had evidence of aortic
or iliac artery involvement.
Vascular imaging. Digital subtraction angiography was per-
formed on the two patients presenting with critical ischemia (patients
1 and 2). Patient 1 had multiple stenoses of the superficial femoral
arteries and occlusion of the right tibioperoneal trunk (Fig 1). Patient
2 had long, smooth narrowing of both popliteal arteries (Fig 2). Both
patients had multiple stenoses of the deep femoral arteries (Fig 1,
A and 2, A) and extensive occlusions of the calf arteries (Fig 1, C
and 2, C).
Duplex sonography was performed on all patients and
iopsy, and laboratory tests for systemic inflammation in
teritis
atient 2 Patient 3 Patient 4
Female/70 Female/61
houlders and
girdle,
lgia, morning
ss, weight loss,
ral headache,
ade fever,
, elevated liver
es
None Pain in shoulders, neck
and pelvic girdle,
arthralgia, weight loss,
fatigue
Not performed Negative
108 84
4.30 6.97
k factors, distribution of peripheral arterial involvement,
l arterial disease due to giant cell arteritis
atient 2 Patient 3 Patient 4
calf, foot and
m claudication,
igital lesions of
eet
Left-leading calf and
foot claudication
Left-leading foot
claudication
m Hg 180/90 mm Hg 160/105 mm Hg
NR† 0.94/0.62
Normal/abnormal Normal/abnormal
Hypertension Hypertension,
smoking
stenoses of
FAs; long,
h stenoses of
As; occlusions
enoses of the
long, smooth
es of both AAs
As
Long occlusion of the
left SFA; circular wall
thickening of the
right SFA, of both
PAs and of the TPAs;
bilateral occlusion of
both Aas
Bilateral, circular
wall thickening of
PAs and TPAs
with multiple
high-grade
stenoses of the
crural arteries
DSA Duplex, PET Duplex, PET
, superficial femoral artery; DFA, deep femoral artery; PA, popliteal artery;
ubtraction angiography;MRI, magnetic resonance imaging; PET, positron
the higher of the two values is shown.
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July 2006178 Tatò and HoffmannFig 1. Digital subtraction angiogram of the right leg of patient 1, a 73-year-old man presenting with critical
lower-limb ischemia. A, Multiple stenoses of the deep femoral artery and irregularities of the superficial femoral artery.
B, Multiple stenoses of the distal superficial femoral artery and the supragenual popliteal artery. C, Occlusion of the
tibioperoneal trunk and of the proximal calf arteries.Fig 2. Digital subtraction angiography of both legs in patient 2, a 58-year-old man with critical ischemia of both feet.
A, Multiple stenoses of both deep femoral arteries. B, Long, smooth narrowing of both popliteal arteries. C, Occlusion
of the posterior tibial and fibular arteries and multiple stenoses of the anterior tibial arteries.
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sonography was able to identify this characteristic finding not
only in the femoropopliteal region but also in the tibial and
peroneal arteries (Fig 3). Patient 3 had a long occlusion of the
left superficial femoral artery. The occlusion was hypoecho-
genic, with the circular wall thickening well visible around the
occluded lumen (Fig 4).
Contrast enhanced MRI of the right popliteal region was
performed on patient 1. T1-weighted MRI of the right popliteal
artery showed circular thickening and marked enhancement of the
arterial wall (Fig 5).
Patients 1, 3, and 4 were evaluated by whole body 18F-FDG-
PET and all showed markedly increased 18F-FDG uptake in the
affected femoropopliteal and crural arteries (Fig 6, A and B).
Abnormal tracer uptake was limited to the femoropopliteal and
crural arteries in patients 1 and 4; the subclavian and axillary
arteries were also involved in patient 3. Involvement of the aorta or
iliac arteries (Fig 6, C) was not evident in any patient.
Follow-up. Once the inflammatory nature of the vascular
Fig 3. Color-coded duplex sonography in patient 4, a
and bilateral foot-claudication. Longitudinal (A) and
hypoechogenic wall thickening.
Fig 4. Color-coded duplex sonography in patient 3, a 7
Longitudinal (A) and enlarged cross-section (B) of the
surrounded by a halo of hypoechogenic wall thickening.disease had been established, all patients were treated medically,and no vascular intervention was performed. All patients received
an initial prednisone dose of 1 mg/kg body weight. Tapering of
the prednisone dose was performed according to the recommen-
dations for GCA, guided by the clinical symptoms and laboratory
signs of systemic inflammation. Patients 1 and 2 were treated with
intravenous prostaglandin E1 (Alprostadil, Schwarz Pharma AG,
Monheim, Germany) for 3 weeks.
Patient 1 showed complete resolution of right-sided rest pain
and healing of the ulceration of the right hallux 4 weeks after
initiation of treatment. Patient 2 has been observed for 19 months.
After the interdigital lesions were healed, he experienced progres-
sive improvement in pain-free walking distance. At his last exami-
nation, ankle pressures had improved to 85/75 mm Hg (right/
left), pulse volume recordings of the feet were pulsatile, and the
self-reported pain-free walking distance was 1000 meters. Patients
3 and 4 were treated with walking exercise. Patient 3 reported an
increase in pain-free walking distance from 50 meters at initial
presentation to 300 meters after 12 months follow-up. At her last
visit, systolic ankle pressures had risen to 170/120mmHg (right/
ar-old woman presenting with polymyalgia rheumatica
-section (B) of the peroneal artery show concentric,
r-old woman presenting with bilateral calf-claudication.
superficial femoral artery show occlusion of the lumen61-ye
cross0-yea
leftleft). Patient 4 was observed by our rheumatology department and
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ment. Hemodynamic measurements were not repeated.
DISCUSSION
Although the cranial arteries are the typical localization
of GCA, this vasculitis may involve any large- or medium-
sized artery. Involvement of extracranial arteries has been
Fig 5. Contrast-enhanced, T1-weighted MRI of the right popli-
teal region of patient 1, a 73-year-old man presenting with critical
lower limb ischemia shows concentric thickening and marked
enhancement of the popliteal artery wall (arrow).
Fig 6. Fluorine-18-desoxyglucose positron emission to
critical lower limb ischemia. Lateral (A) and frontal (B)
vascular tracer uptake. C, Head and trunk of the same patientestimated to occur in 10% to 15% of patients with GCA.
The aorta and the upper limb arteries (particularly the
subclavian and axillary artery) are the most common local-
ization of extracranial GCA. Loss of upper limb pulses is a
well-established symptom of GCA,1,2 and an increased
incidence of aortic aneurysms and dissections is considered
a serious late complication of this disease.14,15
Involvement of the lower limb arteries has been re-
ported in up to 18% of patients with extracranial GCA.4
However, there have been only few reports of patients with
GCA in whom lower limb claudication was the leading
clinical problem,3-7 and GCA is usually not considered a
clinically relevant cause of lower limb ischemia.
We report the cases of four patients who recently pre-
sented to our institution for claudication or critical isch-
emia of the lower limbs and who were found to have GCA
of the femoropopliteal and crural arteries. Based on this
experience, we believe that symptomatic GCA of the lower
limb arteries may be a more common clinical problem than
previously assumed. We have reviewed the symptoms, the
physical findings, and the results of vascular imaging studies
of these four patients to identify the characteristic clinical
features of lower limb GCA.
Lower limb involvement was associated with other,
more typical manifestations of GCA inmost of our patients.
Only one patient presented with calf claudication as the
only symptom. One patient had classic temporal arteritis
with unilateral loss of vision, three patients complained of
fatigue, myalgia, and arthralgia, and two patients had oligo-
or asymptomatic involvement of the axillary and brachial
arteries evident on physical examination. Systemic symp-
raphy in patient 1, a 73-year-old man presenting with
of the popliteal and tibioperoneal arteries show markedmog
viewswithout significant tracer uptake in the central arteries.
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ral arteritis, or signs of upper limb involvement may there-
fore provide the first clinical indication of GCA in patients
presenting with rapidly progressive lower limb ischemia.
Markedly elevated ESR and CRP are a hallmark for the
diagnosis of GCA.1 ESR and CRP were severely elevated in
all our patients, thus supporting the usefulness of labora-
tory tests for systemic inflammation in patients with clau-
dication and suspected large-vessel vasculitis.
A temporal artery biopsy specimen positive for GCA is
generally considered diagnostic proof. Extracranial arteries
are not readily accessible for biopsy. However, histologic
proof of temporal arteritis may also be obtained in patients
presenting only with symptoms of extracranial involve-
ment. In the largest series of histologically documented
extracranial GCA, the rate of positive temporal artery bi-
opsy specimens was 25%.4 Two of three temporal artery
biopsy specimens were positive in our patients. This finding
confirms that temporal artery biopsy is worthwhile in pa-
tients with suspected extracranial GCA.
Abnormal findings on duplex sonography of the tem-
poral artery may facilitate the selection of the biopsy site
and increase the likelihood of a positive biopsy result. In a
recent meta-analysis, ultrasonography of the temporal ar-
tery achieved moderate sensitivity (69%) but good specific-
ity (82%) for the diagnosis of temporal arteritis compared
with temporal biopsy.16
Patients presenting with symptoms of lower limb isch-
emia are frequently evaluated by digital subtraction angiog-
raphy. We performed a digital subtraction angiography on
patients 1 and 2, who presented with critical lower limb
ischemia. Patient 2 had long, smooth narrowing of the
popliteal arteries and multiple “beaded” stenoses of the
deep femoral arteries (Fig 2, B), which would be unusual
for arteriosclerotic vascular disease. Several of our angio-
graphic findings closely resemble arteriosclerosis, however.
The femoropopliteal obstructions shown in Fig 1, B and
the extensive occlusions of tibial and peroneal arteries
present in both patients (Figs 1, C and 2, C) are indistin-
guishable from advanced arteriosclerosis and resemble dia-
betic peripheral arterial disease.
Long, smooth, or beaded appearance of arterial steno-
ses is believed to be suggestive of vasculitis on angiogra-
phy.17 These findings are not specific, however. Beaded
stenoses are also typical of fibromuscular dysplasia,18 and
long, smooth arterial narrowing may be seen in other
noninflammatory conditions such as postinterventional
myointimal hyperplasia, ergotism, or after dissection. The
distinction between vasculitis and other nonarteriosclerotic
vascular disorders should, therefore, include patient his-
tory, distribution of the disease, laboratory tests for inflam-
mation, and assessment of arterial wall morphology by
other imaging techniques. Our data suggest that the angio-
graphic diagnosis of large vessel vasculitis is particularly
unreliable in the femoropopliteal and tibioperoneal arter-
ies, where the angiographic appearance of inflammatory
arterial lesions may be very similar to arteriosclerotic vascu-
lar disease.Suspicion of the presence of a nonarteriosclerotic, in-
flammatory vascular disease was initially triggered in our
patients by the results of duplex sonography. Large-vessel
vasculitis leads to long, circular, hypoechogenic thickening
of the arterial wall, which may be accompanied by a perivas-
cular, hypoechogenic halo.8
The sensitivity and specificity of duplex ultrasound
imaging for the detection of extracranial large-vessel vascu-
litis has not been studied systematically. Published reports
on sonographic findings in extracranial GCA and Takaya-
su’s arteritis,8 as well as our own experience with these
patients, suggest that smooth, circular, hypoechogenic wall
thickening of long arterial segments is virtually pathogno-
monic for large-vessel vasculitis. We have observed a similar
sonographic appearance only in myointimal hyperplasia
after balloon angioplasty, a condition easily distinguishable
from vasculitis by patient history and lack of systemic
inflammation. All of our patients had these typical sono-
graphic changes in the involved vascular segments. The
hypoechogenic wall thickening was visible in the stenosed
and in the occluded arterial segments (Fig 4) and was easily
detectable even in the distal tibial and peroneal arteries (Fig 3).
Lacking histologic proof of vasculitis from the periph-
eral arteries, we cannot totally exclude the coincidence of
GCA and lower limb arteriosclerosis in our patients. How-
ever, based on the typical sonographic appearance of the
affected arteries, the absence of generalized arteriosclerosis,
and the sudden onset of claudication simultaneously with
the systemic symptoms of GCA, we consider arterioscle-
rotic peripheral arterial disease highly unlikely.
We performed contrast-enhanced MRI of the popliteal
region on patient 1 and were able to detect marked thick-
ening and inflammatory enhancement in the wall of the
right popliteal artery (Fig 5). MRI has been shown to have
high sensitivity and specificity for the detection of the
circular wall thickening in large-vessel vasculitis.9,10 Most
studies have focused on the aorta and its major branches,
however, and only very limited data are available on the
performance of MRI in the femoropopliteal or even tibio-
peroneal region.
Presently, we believe that MRI is particularly valuable
for the evaluation of central vascular regions not readily
accessible for high-resolution ultrasonography. A disadvan-
tage of ultrasonography is the persistence of mural thicken-
ing during treatment and the resulting lack of correlation
between sonographic findings and disease activity.8 The
degree of contrast enhancement detected by MRI may
prove superior to sonographic measurements of wall thick-
ness for the follow-up of disease activity.9,10
Recently, 18F-FDG-PET has been introduced in the
evaluation of GCA and Takayasu’s arteritis with very prom-
ising results. This method allows the direct assessment of
vascular inflammation on a whole-body scale, and the level
of vascular FDG uptake was shown to correlate well with
changes in inflammatory activity during treatment.11-13,19
A high aortal FDG-uptake was shown to have a sensitivity
of 92% and a specificity of 100% for the diagnosis of
Takayasu’s arteritis.13 Vascular FDG uptake in the large
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patients with GCA compared with 2% of control subjects.20
The same study reports vascular uptake in the arteries of the
legs in 64% of GCA patients and in 23% of controls. This
finding suggests an unexpectedly high frequency of lower
limb involvement in GCA, but also a lower specificity of
vascular FDG uptake in the arteries of the legs.
Arterial inflammation due to arteriosclerosis is believed
to be the cause of vascular FDG uptake seen in elderly
subjects.21 Most investigators agree that FDG uptake due
to arteriosclerosis is usually mild, whereas a high level of
uptake is suggestive of vasculitis. A cut-off level for distin-
guishing between vasculitis and arteriosclerosis has not
been defined, however.
Presently, 18F-FDG-PET appears to be most valuable
for the early diagnosis of large-vessel vasculitis in young
patients with unspecific symptoms. In elderly patients with
GCA, the results of 18F-FDG-PET need to be interpreted
carefully together with the clinical findings and the results
of other vascular imaging tests. Under these conditions,
18F-FDG-PET provides a unique opportunity to study the
distribution of extracranial vascular inflammation in GCA
patients. Moreover, 18F-FDG-PET may prove to be a very
valuable technique for the follow-up of inflammatory activ-
ity during treatment of large-vessel vasculitis.19
The results of 18F-FDG-PET in our patients confirm a
high degree of tracer uptake in the arterial segments clinically
and sonographically affected by vasculitis. Severe vascular
FDG uptake was limited to the popliteal and crural arteries in
patients 1 (Fig 6) and 4 and also included the axillary arteries
in patient 3. To our knowledge, this is the first report of calf
arteryGCAdetectedby 18F-FDG-PET, thus indicating a high
sensitivity of this technique even in peripheral, medium-sized
arteries.
It is remarkable that none of our patients had evidence of
aortic or iliac artery involvement. This finding suggests that if
GCAaffects the lower limbs, the disease involves preferentially
the crural, femoropopliteal, and deep femoral arteries. In
contrast, large-vessel vasculitis involving the aorta and iliac
arteries may represent a different clinical entity more closely
related to Takayasu’s arteritis. In the future, more widespread
use of 18F-FDG-PET may help to assess the true frequency
and pattern of extracranial involvement in GCA.
Themainstay of treatment ofGCA is immunosuppression
with prednisone. Previous reports indicate that invasive vascu-
lar reconstructions can be avoided in most GCA patients with
peripheral artery involvement.7 Our follow-up data suggest
that even patients with advanced lower limb ischemia due to
GCA can improve substantially with adequate immunosup-
pressive treatment and medical management of peripheral
arterial disease.
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